Asahi Kasei Revamps Medical Business, Welcomes New Investors
Company Announcements

Asahi Kasei Revamps Medical Business, Welcomes New Investors

Asahi Kasei (JP:3407) has released an update.

Asahi Kasei Corp. is restructuring its medical business by establishing Asahi Kasei Life Science Corp. to handle its bioprocess operations, while its subsidiary Asahi Kasei Medical will receive investment from IA Holdings Co., Ltd. through Integral Corporation. The deal will see Asahi Kasei initially transfer 80% of shares in Asahi Kasei Medical to the investing company, with plans to transfer the remaining 20% in the future, aiming to bolster growth and competitiveness in medical devices.

For further insights into JP:3407 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAsahi Kasei Reports Strong Growth in Q2 2024 Earnings
TipRanks Japan Auto-Generated NewsdeskAsahi Kasei Revises Capital Increase Plan for Battery Subsidiaries
TipRanks Japan Auto-Generated NewsdeskAsahi Kasei Announces Share Buyback and Cancellation
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App